Melasma is a benign pigmentary skin disorder. However, it features prominently on sun-exposed areas, typically the face and arms, and as such affects the quality of life of those with the disorder. Radha Chitale spoke with Dr. Gavin Ong Chun Wei, a dermatologist at The Skin Specialist clinic in Singapore, about how GPs can best diagnose and treat patients with melasma.
Atopic dermatitis (AD), also known as atopic eczema, is defined as a chronic or recurrent, itchy inflammatory skin disease. Patients with AD usually have elevated serum immunoglobulin E (IgE) levels and positive family history of asthma, allergic rhinitis and type I allergies. [J Am Acad Dermatol 2014;71(1):116-32]
An 8-year-old girl presents with a six-week history of an erythematous linear lesion on her left thigh (Figure 2). It is slightly raised and scaly but not itchy. The girl has been previously well and the lesion developed quite suddenly, over a few days, and has persisted despite treatment with mometasone furoate 0.1% cream and miconazole cream.
Scar tissue and stretch marks formation are some of the common skin disorders encountered clinically. Scarring occurs when the skin is subjected to trauma (accidents, burns or surgeries) or as a result of certain skin conditions like acne.
Skin infections commonly affect children of all ages. Although more common in those with underlying skin disorders such as atopic dermatitis, the infections can also occur in children without a history of skin disorders. Some skin infections are self-limiting (eg, molluscum contagiosum) and resolve even without treatment. Others such as impetigo may be managed in the primary care setting.
Hair is considered to be a defining feature of a person’s appearance. Whilst hair loss is generally accepted as the norm in males with many men flaunting bald as sexy, many females still find it difficult to come to terms with losing their hair. Excessive hair loss in women impacts on their self esteem and quality of life.
An early and proper therapeutic strategy for acquired cold urticaria (ACU) will only be possible by knowing the clinical predictors of the disease evolution and the clinical features of ACU phenotypes, according to a recent study.
Atopic dermatitis is a chronic, relapsing, pruritic inflammatory skin disease that affects many children and adults. The goal of this activity is to educate pharmacists on atopic dermatitis and the available pharmacotherapies.
Bilastine is a novel second-generation antihistamine that optimizes the treatment of chronic urticaria and allergic rhinitis by effectively balancing its symptom-relieving effects with a unique safety profile. At the recent European Academy of Allergy and Clinical Immunology (EAACI) Congress held in Vienna, Austria, Professor Marcus Maurer of the Charité-Universitätsmedizen, Berlin, Germany, and Associate Professor Marysia Recto of the Asian Hospital and Medical Centre, Muntinlupa City, Philippines, outlined bilastine’s effects on patients with chronic urticaria and allergic rhinitis, while Professor Piotr Kuna from the Medical University of Lodz, Poland, described its unique pharmacokinetics. Their presentations highlighted the unique traits that have ensured that bilastine is the only second-generation antihistamine to meet most of the desired features of an ideal drug described by international guidelines such as ARIA (Allergic Rhinitis and its Impact of Asthma), most notably its rapid onset of action and long-lasting effect, which are achieved without sedation.
Researchers from the US recently demonstrated synergistic effects of topical calcipotriol and 5-fluorouracil (5-FU) for the treatment of actinic keratosis, a known precursor to squamous cell carcinoma (SCC) of the skin.